← Back to Search

Communication Strategies for HPV Vaccination

N/A

Waitlist Available

Led By Noel T Brewer, PhD

Research Sponsored by UNC Lineberger Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from baseline to 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial compares two ways to improve HPV vaccination communication in primary care. Clinics will receive training from outside expert or internal vaccine champion.

Who is the study for?

This trial is for primary care clinics that serve children aged 9-12, specializing in pediatrics or family medicine. Clinics will be enrolled and their staff trained to communicate about HPV vaccination; however, children won't be directly involved.

What is being tested?

The study compares two training methods aimed at improving HPV vaccine discussions: one delivered by an external expert and the other by a 'vaccine champion' from within the healthcare system itself.

What are the potential side effects?

Since this trial focuses on communication training rather than medical interventions, there are no direct side effects related to medications or vaccines being studied.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

HPV vaccination (≥1 dose), 9-12 year olds

Secondary study objectives

HPV vaccination (2 doses), 9-12 year olds

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Traditional AATExperimental Treatment1 Intervention

Staff in clinics randomized to this arm will also receive Announcement Approach Training (AAT). The training will be organized and delivered by outside experts.

Group II: Champion AATExperimental Treatment1 Intervention

Staff in clinics randomized to this arm will receive an intervention called Announcement Approach Training (AAT). This training is designed to improve communication about HPV vaccination. The training will be organized and delivered by vaccine champions from participating healthcare systems.

Do I qualify?Apply below to find out